The pharmaco-invasive strategy with half-dose recombinant human prourokinase in treating patients with acute ST-segment elevation myocardial infarction (STEMI): The 2-year follow-up of bleeding events

Saved in:
Bibliographic Details
Published in:Asian journal of surgery 2024-06, Vol.47 (6), p.2950-2951
Main Authors: Dou, Jie, Yang, Hui-Hui, Wang, Xue-Yan, Luo, Dong-Lei
Format: Article
Language:English
Subjects:
Acute ST-Segment elevation myocardial infarction
Follow up
Major adverse cardiovascular and cerebrovascular events
Primary percutaneous coronary intervention
Recombinant human prourokinase
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:1015-9584
DOI:10.1016/j.asjsur.2024.02.110